280 related articles for article (PubMed ID: 14571790)
1. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
[TBL] [Abstract][Full Text] [Related]
2. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
Pang JZ; Qin LX; Wang QQ; Ren N; Sun BS; Lin GL; Ye QH; Liu YK; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
[TBL] [Abstract][Full Text] [Related]
3. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma].
Niu Q; Tang Z; Ma Z; Qin L; Bao W; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():58-60. PubMed ID: 11509142
[TBL] [Abstract][Full Text] [Related]
5. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between nm23-H1 loss of heterozygosity and metastasis in hepatocellular carcinoma].
Ye Y; Yu Y; Wan D; Tang Z; Lu J; He L
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):161-3. PubMed ID: 11825358
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
[TBL] [Abstract][Full Text] [Related]
8. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
Takada Y; Otsuka M; Todoroki T; Fukao K
Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
10. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
11. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
12. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
13. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
[TBL] [Abstract][Full Text] [Related]
14. [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma].
Wu X; Lin Z; Fan J; Lu J; Wang L; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):189-91. PubMed ID: 12113675
[TBL] [Abstract][Full Text] [Related]
15. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma.
Utsunomiya T; Shimada M; Shirabe K; Kajiyama K; Gion T; Takenaka K; Sugimachi K
Hepatogastroenterology; 2001; 48(40):1088-93. PubMed ID: 11490807
[TBL] [Abstract][Full Text] [Related]
17. Hepatic resection for hepatocellular carcinoma in elderly patients.
Yeh CN; Lee WC; Jeng LB; Chen MF
Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
[TBL] [Abstract][Full Text] [Related]
18. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
Cui BK; Zhang CQ; Zhang Y; Yuan YF; Zhang YQ; Shi M; Chen MS; Li SP; Li JQ
Ai Zheng; 2006 Jul; 25(7):876-9. PubMed ID: 16831281
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.
O'Connell P; Fischbach K; Hilsenbeck S; Mohsin SK; Fuqua SA; Clark GM; Osborne CK; Allred DC
J Natl Cancer Inst; 1999 Aug; 91(16):1391-7. PubMed ID: 10451444
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.
Tang Z; Zhou X; Lin Z; Yang B; Ma Z; Ye S; Wu Z; Fan J; Liu Y; Liu K; Qin L; Tian J; Sun H; He B; Xia J; Qiu S; Zhou J
Chin Med J (Engl); 1999 Oct; 112(10):887-91. PubMed ID: 11717970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
